Evaluation of Diagnostic Biomarkers


Biomarkers provide a characterized bank of immunology which diverse human peripheral blood nonnuclear cells that access the impact of drugs on immune-related protein biomarkers by using multiple readouts and technology platforms. It is also the platform for 3d polycystic kidney disease assays


  • Asses the risk of cytokine release syndrome
  • Biomarkers screening and identification
  • Assay and platform, using human taste bud epithelial cells

Related Conference of Evaluation of Diagnostic Biomarkers

June 25-26, 2024

13th World Congress on Chromatography

Toronto, Canada
August 22-23, 2024

16th International Conference on Clinical Chemistry

Berlin, Germany
October 14-15, 2024

4th International Conference on Analytical Chemistry

Barcelona, Spain
November 13-14, 2024

5th World Expo on Biopolymers and Bioplastics

Dubai, UAE
December 12-13, 2024

23rd World Congress on Nutrition and Food Chemistry

Rome, Italy
December 18-19, 2024

4th International Conference on Petrochemistry and Natural Gas

Amsterdam, Netherlands

Evaluation of Diagnostic Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in